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ABSTRACT.
Purpose: There is a relative paucity of self-reported vision problems data in European countries.
Methods: In this context, we investigated self-reported vision problems through European Health Interview Survey 2, a
cross-sectional European population survey based on a standardized questionnaire including 147 medical, demographic and
socioeconomic variables applied to non-institutionalized individuals aged 15 years or more in 28 European countries, in
addition to Iceland and Norway.
Results: The survey included 311 386 individuals (54.18% women), with overall crude prevalence of self-reported vision
problems of 2.07% [95% CI; 2.01–2.14]. Among them, 1.70 % [1.61–1.78] of men, 2.41% [2.31–2.51] of women and
4.71% [4.53–4.89] of individuals aged 60 or more reported to have a lot of vision problems or to be not able to see. The
frequency of self-reported vision problems was the highest in Eastern European countries with values of 2.43% [2.30–2.56].
In multivariate analyses, limiting long-standing illness, depression, daily smoking, lack of physical activity, lower
educational level and social isolation were associated with self-reported vision problems with ORs of 2.66 [2.42–2.92], 2.16
[2.01–2.32], 1.11 [1.01–1.23], 1.31 [1.21–1.42], 1.29 [1.19–1.40] and 1.45 [1.26–1.67], respectively, while higher income was
associated with less self-reported vision problems with OR of 0.80 [0.73–0.86].
Conclusions: This study demonstrated inequalities in terms of prevalence of self-reported vision problems in Europe, with
higher prevalence in Eastern European countries and among women and older individuals.
Key words: associated factors – epidemiology – Europe – ophthalmology – prevalence – vision impairment – vision loss
#These authors share senior authorship.
Acta Ophthalmol.
ª 2020 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta OphthalmologicaScandinavica Foundation
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
doi: 10.1111/aos.14643
1
Acta Ophthalmologica 2020
Introduction
In addition to reducing educational
and economic opportunities, blindness
and visual impairment have been
linked to lower quality of life, shorter
life expectancy and higher morbidity
(McCarty et al. 2001; Lee et al. 2002;
Thiagarajan et al. 2005; Knudtson
et al. 2006; Cugati et al. 2007; Karpa
et al. 2009; Chakravarthy et al. 2017;
Wang et al. 2017). Identification of
factors that link vision problems with
morbidity and premature death can
assist with prevention and improve
welfare of those with existing vision
impairment.
In 2017, the Global Burden of
Disease Vision Loss Expert Group
published a population-based preva-
lence study of visual impairment and
blindness worldwide, followed by a
paper focussing on prevalence and
causes of vision loss in high-income
countries and in Eastern and Central
Europe (Bourne et al. 2017; Bourne
et al. 2018). In these comprehensive
systematic reviews covering a
twenty-five-year period, the authors
highlighted the paucity of data from
Central and Eastern European coun-
tries. The European Health Interview
Survey (EHIS 2), a European
Union initiative, is a general popula-
tion-based survey providing cross-
sectional national data on health sta-
tus, health determinants and health-
care activities in the European Union.
In this study, we examined associa-
tions between self-reported vision
difficulties in the EHIS 2 and other
variables included in the survey and
other European socioeconomic vari-
ables.
We sought to ascertain the associ-
ation between self-reported vision
problems and other variables of
interest having a potential interaction
with vision problems, identified
through review of the literature.
Specifically, we focused on medical
history of diabetes and depression
(Cosh et al. 2018; Aljied et al.
2018; Yu et al. 2019; Schubert et al.
2019) and potential associated
risk factors including smoking status
(Nita et al. 2017a; Nita et al. 2017;
Mitchell et al. 2018), gender inequity
(Mganga H et al. 2011; Bourne et al.
2017) and social isolation (Brunes
et al. 2019).
Material and Methods
Study design and population
The study was performed under the
auspices of the EUROVISION
research programme, funded by the
European Union Horizon 2020 in 2018
(H2020-EU.1.3.2). The EUROVISION
project aims to describe the prevalence
of self-reported vision problems in
European countries and to identify
related demographic and socioeco-
nomic factors, health determinants
and healthcare access issues. The Euro-
pean Health Interview Survey (EHIS 2)
was performed between 2013 and 2015
and was designed to include popula-
tion-based samples representative of
the European population aged 15 years
and older. People living in collective
households or institutions were
excluded from this survey. The survey
was conducted in 28 member states of
the European Union and in two neigh-
bouring countries (Iceland and Nor-
way).
Procedures
The sampling frame was defined from
population census, population regis-
ters, dwelling registers, national health
insurance registries, postcode address
files or samples from the Labour Force
Survey, depending on the countries
participating in the survey. Using stan-
dardized questionnaires, the data were
collected by face-to-face or telephone
interviews, regular mail, email or
through the Internet, with the majority
of the data originating from telephone
and face-to-face interviews. Eurostat
recommended a minimal required sam-
ple size of 7000 individuals per country.
This sample size was not reached for
member states with a small population
(Slovakia, Slovenia, Sweden, Malta,
Luxembourg, Lithuania, Iceland, Hun-
gary, Croatia, Finland, Estonia, Den-
mark, Czech Republic, Cyprus and
Belgium). For all these countries,
except Malta, Luxembourg and Ice-
land, the number of respondents was
above 5000 (Fig. 1).
The standardized questionnaire
included four different modules com-
prising a demographic and socioeco-
nomic component and public health
category divided into a European
health status module, a European
health determinant module and a
European healthcare module (Table 1).
The questionnaire included 147 vari-
ables in total.
Categorising variables
From the original age groups, two
alternative categorizations have been
created. First, in order to account for
varying top-coding across countries,
age groups 75–79, 80–84, 80+ and 85+
have been merged in one group (75+).
These groups were used for the global
and region-wise univariate analysis, the
multivariate analysis and for age stan-
dardization. Second, in order to reach
a large enough sample size in each
group to obtain reliable results for
logistic regression within each country,
adult individuals have been pooled in
the following groups 18–29, 30–39, 40–
49, 50–59, 60–69 and 70+. These
groups were used for the individual
countries univariate analysis.
Two groups pertaining to vision
status were defined: ‘no vision prob-
lems’ and ‘vision problems’. These
groups were derived from the variable
named PL2 (‘Difficulty in seeing, even
when wearing glasses or contact
lenses’). The possible answers were 1:
‘No difficulty’, 2: ‘Some difficulty’, 3:
‘A lot of difficulty’ and 4: ‘Cannot do
at all/unable to do’. Individuals who
answered 3 or 4 were included in the
‘vision problems’ group. Those who
did not answer were excluded. We
defined ‘unmet need’ for optical cor-
rection as the proportion of respon-
dents within the ‘vision problems’
group who also reported not wearing
an optical correction.
Associated factors
Aside from age and gender, other
variables were created to investigate
their association with vision difficulties.
These variables included education,
wealth, health, daily smoking, daily
alcohol consumption, physical activity,
depression, chronic conditions, func-
tional limitations (for respondents aged
65 years or more), limiting long-stand-
ing illness and social isolation.
Education was categorized into
three levels: ‘low’ for preprimary to
lower secondary education, ‘intermedi-
ate’ for upper secondary to short cycle
tertiary education and ‘higher’ for
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tertiary education and above. Wealth
was coded in two levels: ‘low’ for
income in the lowest quintile and
‘higher’ for income in the other quin-
tiles. Self-assessed health was coded in
two levels: ‘good’ for respondent who
judged their health ‘good’ or ‘very
good’, ‘poor’ for those who answered
‘fair’, ‘bad’ or very ‘bad’. Physical
activitywas coded ‘yes’ if the respondent
walked, used a bike, practiced sports,
fitness or recreational physical activities
for 30 min or more at least once a week,
and ‘no’ otherwise. Depression was
assessed by either a response confirming
depression, or from scoring more than
three negative responses out of six items
relating to mental well-being (chosen to
be as similar as possible to theCenter for
Epidemiologic Studies-Depression
scale). Chronic condition indicators
included self-reported diabetes, heart
problems (coronary heart disease, ang-
ina pectoris or myocardial infarction)
and stroke. The chronic condition indi-
cators were combined into a single
indicator variable encoding ‘one or
more chronic conditions’. Functional
limitations were assessed by different
items including difficulty walking half a
kilometre on level ground, difficulty
walking up or down 12 steps, difficulty
feeding oneself, difficulty getting in and
out of a bed or chair, difficulty dressing
and undressing, difficulty using toilets
and difficulty in bathing or showering.
These items were combined in a single
indicator variable encoding ‘one or
more functional limitations’. This vari-
able was only defined for respondents
aged 65 years and older. Social isolation
was assessed by combining the following
variables: partnership status and inade-
quate financial support. Respondents
who were single and had inadequate
financial support were deemed socially
isolated. Respondents were defined as
either living as a couple (married or not)
or single according to their reported
marital and consensual union status.
Inadequate financial support was
assessed by the inability of respondents
to afford medical examination or treat-
ment over the past 12 months. A more
detailed definition of these variables is
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Fig. 1. Sample size and total weight for EHIS 2. (A) Sample size (number of respondents). (B) Targeted population (sum of unit weights).
Table 1. Composition of public health modules developed into the questionnaires.
European Health Status
Module
European Health
Determinants Module
European Health Care
Module
Health status Weight and height Use of inpatient and day care
services
Specific diseases & chronic
conditions
Physical activity Use of ambulatory and home
care
Occurrence of accidents and
injuries
Consumption of fruits and
vegetables
Medicine use
Absence from work (health
problems)
Smoking behaviour Use of preventive services
Physical & sensory functional
limitations
Alcohol consumption Unmet needs for health care
Difficulties with personal care
activities
Social support
Difficulties with household
activities
Provision of informal care or
assistance
Having pain
Specific aspects of mental
health
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provided in Supporting Information
(Table S1.)
Additional data
In addition to the data collected
through the questionnaires, other
country-level socioeconomic indicators
relating to each country corresponding
to the time of the EHIS survey were
included in the analyses. The Human
Development Index (HDI), the Gender
Inequality Index (GII) and the Inequal-
ity adjusted human development index
(IHDI) were obtained from the United
Nations Development Programme
(http://hdr.undp.org/en/indicators/
137506). The Gross Domestic Product
per capita (GDP), Current Health
Expenditure (CHE) and out-of-pocket
expenditure (% of current health
expenditure) were obtained from the
World Bank (https://data.worldbank.
org/indicator).
Countries participating in the survey
were grouped in four European regions
defined by the United Nations as fol-
lows. Western Europe: Germany, Aus-
tria, Belgium, France, Luxembourg
and The Netherlands; Eastern Europe:
Bulgaria, Hungary, Poland, Czech
Republic, Romania and Slovakia;
Northern Europe: Norway, Iceland,
Ireland, Lithuania, Latvia, UK, Swe-
den, Finland, Denmark and Estonia;
Southern Europe: Croatia, Spain,
Greece, Italy, Malta, Portugal and
Slovenia. Note that while not part of
any region, Cyprus was included in the
overall analysis.
Statistical analysis
All analyses were performed using the
survey unit weights supplied within the
EHIS 2 data set. These made adjust-
ments to the crude data to enhance the
representativeness of the survey data in
relation to the sampled national popu-
lation. According to the survey guide-
lines, they were specified to allow for
overall calculations and inter-country
comparisons, and accounted for sam-
pling design, non-response, gender and
age structure of the populations, and
(in some of the datasets) also regional
distribution and educational attain-
ment. The SAS procedure surveyfreq
was used to compute crude prevalence
and associated 95% confidence inter-
vals (CI) taking these weights into
account.
Odds ratios and their 95% CI were
computed using logistic regression
(SAS surveylogistic procedure), adjust-
ing for age and sex. For the univariate
analysis, only complete observations
for the variable of interest (without
missing data) were used. For the mul-
tivariate analyses, data imputation was
first carried out due to the small
proportion of complete observations
across all variables of interest (61%)
and also to mitigate possible bias due
to a few countries not asking some
questions.
Age-adjusted prevalence and 95%
CIs were computed using the direct
method (SAS stdrate procedure). The
reference population was taken to be
the 5-year wide European (28) popula-
tion data from Eurostat (https://apps
so.eurostat.ec.europa.eu/nui/show.d
o?dataset=demo_pjan&lang=en).
The average was taken for the period
from 2013 to 2015.
Least-square linear regression (SAS
reg procedure) was used for the regres-
sion analyses.
All analyses were performed with
SAS/STAT software, version 9.4 of the
SAS System for Windows. Copyright ©
2016 by SAS Institute Inc. All figures
were created using GraphPad Prism
version 5.03 for Windows, GraphPad
Software, La Jolla California USA.
Results
EHIS 2 included 316,333 participants
of whom 4947 (1.6%) were excluded
because of missing vision status data.
The analysed sample thus consisted of
311 386 respondents (54.18% women),
including 302 093 adults aged 18 or
older and 9293 teenagers aged 15–
17 years old (2.98%). Age group sizes
ranged from 6938 (ages 18–19) to
27 589 (ages 50–54). Of the sample
analysed, 55.81% of men and 66.37%
of women reported that they wore
glasses or contact lenses, and 1.84%
of men and 2.91% of women reported
vision problems.
The overall crude prevalence of self-
reported vision problems was 2.07%
[2.01–2.14]. Among people reporting
vision problems in Europe (2.07%),
almost a quarter (26%) did not report
using optical correction (0.54%). The
unmet need for optical correction
despite vision problems was 20% in
Eastern, 25% in Northern, 30% in
Southern and 41% in Western
European regions. Considering the
analysis by region and country, respon-
dents in Southern and Western Euro-
pean countries showed similar crude
prevalence of self-reported vision prob-
lems with values of 2.29% [2.17–2.41]
and 2.17% [2.03–2.31], respectively
(OR and 95% CI for Western versus
Southern country: 1.01 [0.92–1.09]). On
the other hand, Eastern and Northern
countries, respectively, had the highest
and lowest crude prevalence with val-
ues of 2.43% [2.30–2.56] and 1.25%
[1.14–1.36] (OR and 95% CI for
Northern versus Eastern country: 0.49
[0.44–0.54]). The remaining ORs and
95% CI are as follows: Southern versus
Eastern: 0.82 [0.76–0.89]; Western ver-
sus Eastern: 0.83 [0.76–0.90]; Southern
versus Northern: 1.69 [1.52–1.88]; Wes-
tern versus Northern: 1.70 [1.52–1.91].
Among each region, there were consid-
erable inter-country differences, rang-
ing from 0.86 [0.66–1.06] and 0.86
[0.59–1.13] in Ireland and Malta,
respectively, to 4.31% [3.91–4.70] and
6.48 [5.76–7.19] in Portugal and Bel-
gium, respectively. These data are
detailed by region and by country for
three age groups (<18, 18–65, ≥60 years
old) and by gender in Table 2.
Women reported significantly more
vision problems than men did with
overall age-adjusted prevalence of self-
reported vision problems of 2.41%
[2.31–2.51] versus 1.70% [1.61–1.78],
respectively (OR and 95% CI: 1.43
[1.34–1.54]).
Among older participants, women
reported more vision problems than
males, with an age-adjusted prevalence
of 5.65% [5.38–5.92] for women and
3.62% [3.40–3.84] for males in the age
group of 60+ years (OR and 95% CI:
1.60 [1.47–1.74]), reaching 17.22%
[15.68–18.76] for women and 11.85%
[10.25–13.45] for males in the age
group of 85+ years (OR and 95% CI:
1.55 [1.28–1.87]). These results are
displayed in Table 3.
The association between various fac-
tors of interest and self-reported vision
problems was investigated in adults
(18 years old and older). Among other
factors, depression and social isolation
were associated with vision problems,
with ORs of 4.55 [4.20–4.93] and 2.79
[2.43–3.21], respectively. Among those
aged 65 years and more, functional
limitations were associated with ORs
of self-reported vision problems of 6.04
[5.31–6.87]. These results of the
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Table 2. Crude prevalence (%) of self-reported vision problems provided by region and by country for three age groups and by sex.
All
Age Need for optical correction
15–17 18-59 60+ Met Unmet
Europe 2.07 [2.01–2.14]
N = 311 386
0.49 [0.30–0.68]
N = 9293
1.02 [0.96–1.08]
N = 194 912
4.71 [4.53–4.89]
N = 107 181
1.53 [1.47–1.59]
N = 191 603
0.54 [0.51–0.58]
N = 119 783
East 2.43 [2.30–2.56]
N = 65 182
0.52 [0.21–0.83]
N = 2024
0.94 [0.83–1.04]
N = 40 257
6.34 [5.96–6.71]
N = 22 901
1.94 [1.83–2.06]
N = 32 534
0.49 [0.43–0.55]
N = 32 648
Bulgaria 2.10 [1.76–2.44]
N = 6400
0.00 [0.00–0.00]
N = 188
0.43 [0.23–0.64]
N = 3829
5.64 [4.68–6.60]
N = 2383
1.40 [1.12–1.68]
N = 2978
0.70 [0.50–0.90]
N = 3422
Czech Republic 2.04 [1.71–2.38]
N = 6737
0.00 [0.00–0.00]
N = 120
0.88 [0.53–1.22]
N = 3408
4.79 [4.00–5.58]
N = 3209
1.78 [1.46–2.09]
N = 4507
0.27 [0.15–0.38]
N = 2230
Hungary 2.63 [2.21–3.06]
N = 5825
1.76 [0.00–3.77]
N = 204
1.54 [1.15–1.93]
N = 3891
5.20 [4.11–6.29]
N = 1730
1.79 [1.44–2.15]
N = 2899
0.84 [0.60–1.08]
N = 2926
Poland 3.17 [2.92–3.41]
N = 24 125
0.80 [0.25–1.35]
N = 874
1.25 [1.05–1.44]
N = 15 390
8.53 [7.80–9.27]
N = 7861
2.66 [2.44–2.88]
N = 13 343
0.51 [0.41–0.61]
N = 10 782
Romania 1.62 [1.42–1.82]
N = 16 605
0.00 [0.00–0.00]
N = 498
0.39 [0.26–0.51]
N = 10 104
4.86 [4.23–5.49]
N = 6003
1.18 [1.02–1.35]
N = 5702
0.43 [0.33–0.54]
N = 10 903
Slovakia 1.10 [0.84–1.35]
N = 5490
0.00 [0.00–0.00]
N = 140
0.43 [0.23–0.64]
N = 3635
3.20 [2.37–4.04]
N = 1715
1.00 [0.76–1.25]
N = 3105
0.09 [0.02–0.16]
N = 2385
North 1.25 [1.14–1.36]
N = 76 999
0.48 [0.12–0.83]
N = 2203
0.77 [0.65–0.90]
N = 45 941
2.50 [2.25–2.75]
N = 28 855
0.93 [0.84–1.03]
N = 50 878
0.32 [0.26–0.38]
N = 26 121
Denmark 1.00 [0.75–1.25]
N = 5510
0.50 [0.00–1.48]
N = 163
0.67 [0.40–0.95]
N = 3169
1.81 [1.23–2.40]
N = 2178
0.59 [0.40–0.78]
N = 3910
0.41 [0.25–0.57]
N = 1600
Estonia 2.25 [1.86–2.65]
N = 5449
0.81 [0.00–2.40]
N = 185
0.65 [0.39–0.92]
N = 3440
6.15 [4.98–7.33]
N = 1824
1.68 [1.34–2.02]
N = 3364
0.57 [0.36–0.78]
N = 2085
Finland 1.92 [1.57–2.27]
N = 5982
0.00 [0.00–0.00]
N = 178
1.31 [0.91–1.71]
N = 3287
3.38 [2.63–4.13]
N = 2517
1.59 [1.27–1.91]
N = 4446
0.34 [0.19–0.49]
N = 1536
Iceland 1.13 [0.80–1.46]
N = 3991
0.00 [0.00–0.00]
N = 227
0.81 [0.45–1.16]
N = 2680
2.37 [1.47–3.27]
N = 1084
0.93 [0.64–1.23]
N = 2459
0.20 [0.06–0.34]
N = 1532
Ireland 0.86 [0.66–1.06]
N = 9567
0.00 [0.00–0.00]
N = 74
0.59 [0.37–0.82]
N = 5986
1.90 [1.42–2.38]
N = 3507
0.63 [0.45–0.80]
N = 6229
0.23 [0.13–0.33]
N = 3338
Latvia 2.69 [2.32–3.06]
N = 7068
0.00 [0.00–0.00]
N = 241
0.87 [0.57–1.16]
N = 4296
7.06 [6.04–8.08]
N = 2531
1.47 [1.20–1.74]
N = 2892
1.22 [0.96–1.48]
N = 4176
Lithuania 2.05 [1.69–2.41]
N = 5205
1.02 [0.00–2.43]
N = 194
0.81 [0.50–1.12]
N = 3139
5.11 [4.12–6.10]
N = 1872
1.42 [1.12–1.72]
N = 2622
0.63 [0.43–0.83]
N = 2583
Norway 0.92 [0.68–1.16]
N = 8161
0.65 [0.00–1.61]
N = 319
0.62 [0.39–0.85]
N = 5467
1.72 [1.05–2.39]
N = 2375
0.71 [0.50–0.92]
N = 5184
0.21 [0.10–0.33]
N = 2977
Sweden 1.60 [1.25–1.95]
N = 5939
0.22 [0.00–0.64]
N = 274
1.10 [0.77–1.42]
N = 4051
2.87 [1.96–3.78]
N = 1614
1.13 [0.83–1.42]
N = 3868
0.47 [0.28–0.67]
N = 2071
United Kingdom 1.11 [0.95–1.27]
N = 20 127
0.58 [0.00–1.17]
N = 348
0.72 [0.54–0.91]
N = 10 426
2.15 [1.80–2.49]
N = 9353
0.86 [0.72–0.99]
N = 15 904
0.25 [0.16–0.34]
N = 4223
South 2.29 [2.17–2.41]
N = 89 132
0.46 [0.12–0.80]
N = 2406
0.92 [0.82–1.02]
N = 54 071
5.47 [5.15–5.78]
N = 32 655
1.60 [1.51–1.70]
N = 53 854
0.69 [0.62–0.75]
N = 35 278
Croatia 2.95 [2.47–3.43]
N = 5396
1.48 [0.00–3.29]
N = 185
1.12 [0.73–1.51]
N = 3272
7.10 [5.80–8.40]
N = 1939
2.36 [1.92–2.80]
N = 2871
0.59 [0.38–0.80]
N = 2525
Greece 2.28 [1.96–2.61]
N = 8216
0.00 [0.00–0.00]
N = 120
0.63 [0.39–0.87]
N = 4734
5.98 [5.08–6.87]
N = 3362
1.81 [1.53–2.09]
N = 4719
0.47 [0.31–0.63]
N = 3497
Italy 2.04 [1.85–2.22]
N = 24 256
0.50 [0.00–1.00]
N = 793
0.73 [0.58–0.87]
N = 15 046
4.77 [4.29–5.25]
N = 8417
1.51 [1.35–1.66]
N = 13 861
0.53 [0.43–0.62]
N = 10 395
Malta 0.86 [0.59–1.13]
N = 4045
1.13 [0.00–3.33]
N = 109
0.37 [0.14–0.60]
N = 2459
2.04 [1.32–2.77]
N = 1477
0.65 [0.42–0.89]
N = 2715
0.21 [0.07–0.35]
N = 1330
Portugal 4.31 [3.91–4.70]
N = 18 194
0.22 [0.00–0.58]
N = 435
2.41 [2.02–2.80]
N = 10 503
8.79 [7.85–9.73]
N = 7256
2.79 [2.48–3.10]
N = 11 086
1.52 [1.27–1.76]
N = 7108
Slovenia 2.50 [2.08–2.93]
N = 6195
0.41 [0.00–1.22]
N = 243
1.28 [0.89–1.66]
N = 3978
5.64 [4.49–6.78]
N = 1974
2.03 [1.65–2.41]
N = 3723
0.47 [0.28–0.67]
N = 2472
Spain 2.10 [1.89–2.31]
N = 22 830
0.47 [0.00–1.18]
N = 521
0.87 [0.69–1.05]
N = 14 079
5.39 [4.81–5.98]
N = 8230
1.33 [1.17–1.49]
N = 14 879
0.77 [0.64–0.90]
N = 7951
West 2.17 [2.03–2.31]
N = 75 115
0.51 [0.12–0.90]
N = 2439
1.29 [1.16–1.41]
N = 51 286
4.45 [4.07–4.83]
N = 21 390
1.59 [1.47–1.71]
N = 51 591
0.59 [0.51–0.66]
N = 23 524
Austria 1.39 [1.09–1.69]
N = 15 771
0.00 [0.00–0.00]
N = 252
0.74 [0.57–0.91]
N = 11 732
3.19 [2.18–4.19]
N = 3787
1.17 [0.88–1.46]
N = 10 940
0.22 [0.13–0.32]
N = 4831
Belgium 6.48 [5.76–7.19]
N = 9110
1.23 [0.00–2.65]
N = 340
4.39 [3.63–5.15]
N = 6064
12.24 [10.54–13.94]
N = 2706
4.71 [4.15–5.28]
N = 5663
1.76 [1.31–2.21]
N = 3447
France 2.44 [2.16–2.73]
N = 15 481
0.61 [0.00–1.36]
N = 611
1.40 [1.14–1.66]
N = 10 061
5.05 [4.30–5.80]
N = 4809
2.07 [1.80–2.33]
N = 11 005
0.38 [0.27–0.49]
N = 4476
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univariate analysis are detailed in
Table 4. Poor self-rated health, limiting
long-standing and chronic illness, daily
smoking were associated with more
self-reported vision problems with
ORs of 4.48 [4.11–4.89], 5.23 [4.82–
5.67], 2.53 [2.34–2.73], 1.35 [1.23–1.48],
respectively, while higher wealth and
education level were associated with
less self-reported vision problems, with
ORs of 0.60 [0.55–0.65] and 0.77 [0.68–
0.87], respectively. The results of the
univariate analysis by region and coun-
tries are detailed in Fig. 2 and in
supporting Information (Table S2).
Multivariate regression analysis
between self-reported vision problems
and health, socioeconomic and life-
style-related variables showed that lim-
iting long-standing illness and
depression were associated with self-
reported vision problems with ORs of
2.66 [2.42–2.92] and 2.16 [2.01–2.32],
respectively. Smoking, physical activ-
ity, education level, economic status
and social isolation were also associ-
ated with self-reported vision prob-
lems. These results are detailed in
Table 5.
No statistically significant associa-
tion between age-adjusted prevalence
and socioeconomic indicators was
found at the country level.
Discussion
The EHIS2 population-based survey
provides data on self-reported vision
problems and associated factors for 30
countries in Europe, country by coun-
try. The crude overall prevalence of
self-reported vision problems was
2.07% [2.01–2.14].
For those aged 60 years or more, the
crude prevalence of vision problemswas
4.71% [4.53–4.89]. These results are
slightly different from other popula-
tion-based studies of self-reported
vision status in other high-income
regions including the National Health
Interview Survey (NHIS) (Lam et al.
2009), the National Health and Nutri-
tion Examination Survey IV (NHANES
IV) (Coyle et al. 2017) and the English
Longitudinal Study on Ageing (ELSA)
(Jackson et al. 2019). The comparison of
self-reported vision problems preva-
lence in these different population-based
studies is detailed in supporting Infor-
mation (Table S3).
It is likely that these differing results
firstly reflect the variability in the
wording of visual health questions
included in different surveys. Secondly,
they reflect differing categorization of
responses, making meaningful compar-
ison between studies challenging. For
example, in the NHIS, visual health
questions were ‘Do you have any
trouble seeing, even when wearing
glasses or contact lenses?’ and ‘Are
you blind or unable to see at all?’.
Participants were classified as visually
impaired if they responded yes to either
question (Lam et al. 2009). In the
NHANES IV, participants were asked
to rate their corrected vision as excel-
lent, good, fair, poor or very poor.
Three groups were defined from the
answers: poor or very poor vision,
vision categorized as fair and good or
excellent vision for the reference group
(Coyle et al. 2017). This categorization
of self-reported vision problems was
different to that which we used for
EHIS 2, in which we reduced this
categorization from four levels to two
categories of vision problems. In
ELSA, participants were asked if their
corrected eyesight was excellent, very
good, good, fair or poor. Respondents
reporting fair or poor vision were
classified in the ‘poor vision’ group
(Yu et al. 2019) whereas the criteria
used to define ‘vision problems’ group
in the current study were more conser-
vative. These differences are likely to
explain the variability of observed
prevalence of self-reported vision prob-
lems for similar age groups. In this
context, we strongly support Rein,
D.B. and colleagues in advocating
Table 2 (Continued)
All
Age Need for optical correction
15–17 18-59 60+ Met Unmet
Germany 1.29 [1.11–1.47]
N = 23 241
0.40 [0.00–0.97]
N = 772
0.65 [0.51–0.80]
N = 15 707
2.86 [2.36–3.36]
N = 6762
0.60 [0.48–0.72]
N = 15 943
0.69 [0.56–0.83]
N = 7298
Luxembourg 2.74 [2.20–3.28]
N = 3860
2.59 [0.00–5.61]
N = 115
2.71 [2.09–3.33]
N = 2840
2.85 [1.67–4.03]
N = 905
2.68 [2.14–3.21]
N = 2607
0.06 [0.00–0.14]
N = 1253
Netherlands 3.15 [2.74–3.55]
N = 7652
0.28 [0.00–0.82]
N = 349
2.23 [1.79–2.66]
N = 4882
5.84 [4.85–6.84]
N = 2421
2.82 [2.43–3.20]
N = 5433
0.33 [0.19–0.47]
N = 2219
The 95% CI are given between brackets. An individual was considered to have vision problems if he declared having a lot of difficulty or not being
able to see at all when answering to the item ‘difficulty in seeing, even when wearing glasses or contact lenses’. An individual was considered to have
no vision problem if he/she answered that they had no difficulty or some difficulty in seeing. Note that Europe includes Cyprus, which was not part of
any region defined by the United Nations.
Table 3. Age-adjusted prevalence of self-reported vision problems by sex for older individuals.
Age Gender N Prevalence (%) [95% CI] OR (95% CI)
All M 142 662 1.70 [1.61–1.78] 1.43 [1.34–1.54]
F 168 724 2.41 [2.31–2.51]
50+ M 72 285 2.9 [2.74–3.05] 1.52 [1.41–1.63]
F 85 599 4.32 [4.13–4.51]
60+ M 46 953 3.62 [3.40–3.84] 1.60 [1.47–1.74]
F 60 228 5.65 [5.38–5.92]
70+ M 23 136 5.07 [4.70–5.45] 1.67 [1.52–1.85]
F 32 218 8.18 [7.74–8.62]
85+ M 2677 11.85 [10.25–13.45] 1.55 [1.28–1.87]
F 4967 17.22 [15.68–18.76]
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improved standardization of the phras-
ing of self-reported vision status ques-
tions, to enhance both reproducibility
and comparability of national popula-
tion-based surveys (Rein et al. 2018).
The Sustainable Development Goals
(SDGs), adopted by the United
Nations General Assembly in 2015,
provide a new global policy framework
aiming at fighting inequalities in social,
economic, health and environmental
aspects. Among the first five SDGs, are
‘no poverty’ (1st), ‘good health and
well-being’ (3rd), ‘quality of education’
(4th) and ‘gender equality’ (5th).
Through the present analysis of the
EHIS data, we were able to gain some
insight into the association between the
SDGs and vision impairment by the
inclusion of gender, socioeconomic
(income, education, social isolation
and discrimination) and health data
(smoking, chronic illness and func-
tional limitation, depression).
Exploring this further, it becomes
apparent that women and older
respondents were more prone to report
vision problems. Indeed, the age-ad-
justed prevalence of self-reported
vision problems was 2.41% [2.31–
2.51] for women in EHIS 2, compared
to 1.70% [1.61–1.78] for males (OR
and 95% CI: 1.43 [1.34–1.54]).
Furthermore, when focusing on the
elderly population, the age-adjusted
prevalence of vision problems was
consistently higher among women than
males (Table 3). In the European pop-
ulation, this gender difference could
reflect better self-awareness of vision
impairment or less tolerance to poor
vision in women, or true gender differ-
ences in the prevalence of vision
impairment, relating to differences in
the prevalence of underlying eye dis-
ease or to differential access to eye care
services and treatments. Comparison
to other studies is difficult because data
on the association between gender and
self-reported vision problems are lack-
ing. However, our results are very
similar to a population-based Cana-
dian study, which reported that the
prevalence of self-reported uncorrected
vision problems was 2.0% among
women and 1.3% among males (Per-
ruccio et al. 2010). More widely,
inequality between women and males
has been reported in a systematic
review (Bourne et al. 2017). In that
review, the authors observed that the
prevalence of blindness and moder-
ately or severely impaired vision was
higher in women than in males for all
age groups (0–49, 50–69 and ≥70). In
line with other population-based
studies, the current study confirmed
that older individuals carry a much
higher risk of visual impairment. In
EHIS 2, the crude prevalence of vision
problems among respondents aged 70+
years was 6.88%, while the prevalence
of poor vision and legal blindness was
reported to be 9.08% in the 2010
Health and Retirement Study (HRS)
including Americans aged 70+ years
(Chen et al. 2016). In the US, the
Vision and Eye Health Surveillance
System (VEHSS) in the American
community survey based on IRIS reg-
istry estimated that 5.60% [95% CI:
5.50–5.70] of individuals aged 65–
84 years and 17% [95% CI: 16.80–
17.60] of individuals aged 85+ years
considered themselves to be blind or to
have serious difficulties in seeing, even
when wearing glasses.
Our univariate logistic regression
analysis showed that even for respon-
dents in the same country, both higher
income and higher education levels
were protective factors for self-reported
vision problems, with ORs of 0.60
[0.55–0.65] and of 0.77 [0.68–0.87],
respectively. These results were par-
tially confirmed in multivariate analy-
ses which showed that higher income
had a protective effect, with OR of 0.80
[0.73–0.86] while lower education level
increased the risk with an OR of 1.29
[1.19–1.40].
Lower income has been frequently
reported among blind or visually
impaired individuals (Brezin et al.
2005). A recent study investigating the
prevalence of visual impairment under
the scope of socioeconomic factors at
country level showed that a higher
Human Development Index and Edu-
cation Index were associated with a
lower prevalence of blindness or mod-
erate and severe visual impairment
(Wang et al. 2017). Meanwhile, lower
total health expenditure per capita and
total health expenditure by Gross
Domestic Product were associated with
higher prevalence (Wang et al. 2017).
We also analysed the relationship
between socioeconomic indicators and
self-reported vision problems at the
country level, but no significant asso-
ciation with a country’s HDI, IHDI,
GDP, out of pocket expenditure, MPI
and GII could be established. This may
be because socioeconomic level does
not differ sufficiently among member
states to detect significant difference,
but it is more likely that the
Table 4. Univariate regression analysis between self-reported vision problems and health,
socioeconomic and lifestyle-related variables in Europe in the adult population.
EHIS 2 (N = 302 093)
OR [95% CI]
% Missing values
among respondents
Missing
countries
Physical health
Self-rated health (poor versus good) 4.48 [4.11–4.89] 3.00 -
Limiting long-standing illness (yes
versus no)
5.23 [4.82–5.67] 1.64 -
Chronic illness (yes versus no) 2.53 [2.34–2.73] 1.39 -
Functional limitations (yes versus no;
age 65+)
6.04 [5.31–6.87] 3.62 NL, BE
Mental health
Depression (yes versus no) 4.55 [4.20–4.93] 13.90 BE, ES, NL
Lifestyle
Daily smoking (yes versus no) 1.35 [1.23–1.48] 1.53
Physical activity (no versus yes) 2.26 [2.09–2.44] 9.26 BE, NL
Near-daily alcohol consumption (yes
versus no)
0.81 [0.71–0.93] 18.50 FR, IT, NL
Economics
Wealth (higher versus low) 0.60 [0.55–0.65] 6.47 -
Education (high versus intermediate) 0.77 [0.68–0.87] 0.69 -
Education (low versus intermediate) 1.74 [1.61–1.89] 0.69 -
Social life
Social isolation (yes versus no) 2.79 [2.43–3.21] 11.72 BE, FR
‘Missing countries’ refers to those countries which did not ask one or more of the questions used
to define the corresponding combined variable.
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socioeconomic associations we found
at survey participant level are not
reflected by the rather crude compar-
ison of country-level summary mea-
sures like these. Moreover, the small
number of data points (30 countries)
fundamentally limits the power of this
analysis.
In agreement with other studies
(Bourne et al. 2018), the current study
also showed that self-reported vision
problems were still more prevalent in
Eastern (2.43%) than in Northern
(1.25%), Western (2.17%) and South-
ern (2.29%) European countries while
the unmet needs of optical correction
were the lowest in Eastern European
countries (20%, see Table 2). In this
context, it is likely that impact of
ocular diseases on vision is more
important than in other European
regions. For Eastern countries, it is
likely that a favourable economic evo-
lution has not yet completely led to
medical policies guaranteeing an
improved access to affordable medical
care. Furthermore, positive economic
growth does not necessarily equate to
reduced inequalities between individu-
als, as can be clearly observed from
data on the Gini coefficient of equival-
ized disposable income published by
EU-SILC (https://ec.europa.eu/eurosta
t/web/microdata/european-union-sta
tistics-on-income-and-living-condi
tions). We also investigated if the
payment by the national social system
for eye examinations in the elderly
(50+) has an impact on self-declared
vision problems. There was apparently
no correlation, probably because many
other factors can also interact such as
the pocket-to-pocket expenditure for
eye examination or the level of reim-
bursement of optical correction by
social security or by insurances. In
parallel to socioeconomic aspects,
social isolation, a variable defined by
combining celibacy and inadequate
financial support, was a related risk
factor for vision problems in the uni-
variate analyses. Our cross-sectional
study also supports previous published
studies which reported an association
between visual impairment and depres-
sion, particularly in the elderly popu-
lation (Rovner et al. 1997; Evans et al.
2007; Goldstein et al. 2012; Yip et al.
2014; Ribeiro et al. 2015; Van der Aa
et al. 2015; Yu et al. 2019).
Multivariate analysis also showed
that smoking status was a related risk
factor for self-reported vision prob-
lems, with an OR of 1.11 [1.01–1.25]
for smokers compared with non-smok-
ers (Table 5). Other studies found sim-
ilar results (Zhang et al. 2011).The
association between smoking and
vision problems could be explained by
an increased risk of cataract (Kang
et al. 2016) and age-related macular
degeneration (AMD) among smokers
(Christen et al. 1996; Age-Related Eye
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Fig. 2. Odds ratios and 95% confidence intervals from the univariate regression analysis between vision problems and variables of interest, by region
and by country, in adult population. Only variables defined from questions answered by all countries were included, namely (A) Self-assessed health
(poor versus good); (B) limiting long-standing illness (yes versus no); (C) chronic illness (yes versus no); (D) daily smoking (yes versus no); (E) wealth
(high versus low); (F) education (low versus intermediate); (G) education (high versus intermediate). The ORs of the education variable could not be
computed for Malta and Portugal because no survey specified a high level of education.
Table 5. Multivariate regression analysis between self-reported vision problems and health,
socioeconomic and lifestyle-related variables in Europe in the adult population.
EHIS 2 (N = 302 093)
OR [95% CI]
Physical health
Self-rated health (poor versus good) 1.87 [1.69–2.07]
Limiting long-standing illness (yes versus no) 2.66 [2.42–2.92]
Chronic illness (yes versus no) 1.46 [1.35–1.57]
Mental health
Depression (yes versus no) 2.16 [2.01–2.32]
Lifestyle
Daily smoking (yes versus no) 1.11 [1.01–1.23]
Physical activity (no versus yes) 1.31 [1.21–1.42]
Near-daily alcohol consumption (yes versus no) 0.93 [0.80–1.08]
Economics
Wealth (higher versus low) 0.80 [0.73–0.86]
Education (high versus intermediate) 0.95 [0.84–1.08]
Education (low versus intermediate) 1.29 [1.19–1.40]
Social life
Social isolation (yes versus no) 1.45 [1.26–1.67]
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Disease Study Research Group et al.
2000; Klein et al. 2004).
We acknowledge some weaknesses
in the current study. Firstly, some
questions of interest were not asked in
a few countries, which rendered diffi-
cult the comparison of odds ratios
between different variables, and
between the univariate and the multi-
variate analyses for the same variable.
Secondly, heterogeneity between coun-
tries in the data gathering process may
have been a source of measurement or
selection bias, and this should be kept
in mind when interpreting the results.
While the prevalence of self-reported
vision problems by age group, country
and gender provide a useful pan-Euro-
pean insight into the epidemiology of
self-reported vision impairment, the
cross-sectional nature of the study
design did not enable us to establish
causal links between vision problems
and explanatory variables. Thirdly, the
study design of the survey did exclude
people living in collective households
or institutions, probably leading to an
under-estimation of self-reported
vision problems in the whole European
population. Finally, the NEI-VFQ-25
questionnaire was not used into this
survey because it was dedicated not
only to vision problems, but also to
wider aspects of health determinants,
which are not explored with the NEI-
VFQ-25 questionnaire. The EHIS 2
survey questionnaire was tested on
population samples in different coun-
tries before being used widely on the
European scale. Considering the few
questions related to vision in EHIS 2,
they were validated by the Washington
Group on Disability Statistics short set
of question that provided evidence that
these questions were able to capture
different aspects of difficulties in seeing.
We did not useRasch analysis tomap
item responses to individual abilities,
because this approach has several draw-
backs. First, the resulting model would
be much more difficult to interpret.
Specifically, dependent variables values
expressed in logits might no longer be
related, even partially, to answers to
questionnaire items. Moreover, the
resulting effect size expressed in odds
ratio in the current studycouldno longer
be interpretable in simple terms, which
would limit our results to ‘positively or
negatively associated’. Second, as this
approach is not currently widespread in
the epidemiology community, its use
would have rendered our results less
accessible. There are only a few pub-
lishedEuropeanpopulation-based stud-
ies on prevalence of vision impairment
and blindness (measuring visual acuity
of participants rather than self-report-
ing) by cause, some of them focusing on
specific European countries (Munier
et al. 1998; Cruciani et al. 2011; Finger
et al. 2012; Havstam Johansson et al.
2020) and others having a more global
focus (Flaxman et al. 2017; Bourne et al.
2018; Nemeth et al. 2019). According to
the Vision Loss Expert Group, uncor-
rected refractive errors, cataract, AMD
and glaucoma, that are entirely or partly
curable pathologies, were still the main
causes of both blindness andmoderately
to severely impaired vision in Western,
Central andEasternEuropean countries
(Bourne et al. 2018). Nevertheless, pop-
ulation-based data on the prevalence
and causes of vision problems, stratified
by region and by age group, are still
missing formost EuropeanUnionmem-
ber states. In that respect, the EHIS 2
developed and funded by the European
Union represents an excellent opportu-
nity to gather data on the health status,
healthcare use and health determinants
in every member state. These data, in
turn, should be useful for European and
local public health policies in their
efforts to improve access to health ser-
vices for all and to decrease inequalities
(Nemeth et al. 2019). A strength of our
study is the large size of the representa-
tive population sample, which allowed
the analyses to be carried out at the level
of participating countries, namelymem-
ber states of Europe.
Conclusion
This cross-sectional European popula-
tion-based study demonstrates inequal-
ities between European Union member
states in terms of crude prevalence of
self-reported vision problems, ranging
from 0.86% (in Ireland and Malta) to
6.48% (in Belgium) in the general
population, with higher prevalence in
Eastern European countries. Further-
more, self-reported vision problems in
Europe were more frequently observed
in the elderly, women, smokers, and in
those reporting greater social isolation.
Higher prevalence of eye disorders in
older individuals combined with other
physical limitations, better self-aware-
ness of vision problems and economic
restrictions limiting access to eye care
services could explain these differences.
Given that this study reports 26% of
people with an unmet need for optical
correction in Europe, efforts should be
upscaled to address this requirement.
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